Introductory paper: High-dose influenza vaccine

Vaccine. 2021 Mar 15:39 Suppl 1:A1-A5. doi: 10.1016/j.vaccine.2020.09.005. Epub 2021 Feb 3.

Abstract

Seasonal influenza has a significant impact on global public health each year, especially in older adults 65 years of age and above. This paper presents the evolution of high-dose influenza vaccine and the quantity as well as quality of evidence on this vaccine. Its introduces other peer-reviewed manuscripts included in this supplement covering the benefits high-dose influenza vaccine over ten consecutive influenza seasons. The development of the high-dose influenza vaccine represents an important step in the evolution of influenza vaccines, offering an advancement in prevention of influenza and a step in encouraging healthy aging in older adults. A video summary of the article can be accessed via the Supplementary data link at the end of this article.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Global Health
  • Humans
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Seasons
  • Vaccination

Substances

  • Influenza Vaccines